Association Between the Serum Uric Acid to Albumin Ratio and the No-Reflow Phenomenon After Percutaneous Coronary Intervention (PCI): A Systematic Review and Meta-Analysis. [PDF]
Ozbay MB +6 more
europepmc +1 more source
Role of Intracoronary Adrenaline in the Treatment of No-Reflow Phenomenon in Patients Undergoing Percutaneous Coronary Intervention. [PDF]
Simoni L +4 more
europepmc +1 more source
Clinical, laboratory, and procedural predictors of slow flow/no reflow phenomenon after emergency percutaneous coronary interventions in ST-elevated myocardial infarction. [PDF]
Bamarinejad F +7 more
europepmc +1 more source
The HALP score predicts no-reflow phenomenon and long-term prognosis in patients with ST-segment elevation myocardial infarction after primary percutaneous coronary intervention. [PDF]
Liu H +7 more
europepmc +1 more source
The assessment of no-reflow phenomenon incidence in early versus delayed percutaneous coronary intervention following a primary fibrinolysis. [PDF]
Amirpour A +10 more
europepmc +1 more source
Paving the way for improving no-reflow phenomenon
openaire +3 more sources
Predictive value of the triglyceride-glucose index for no-reflow phenomenon after percutaneous coronary intervention in patients with acute ST-segment elevation myocardial infarction complicated by metabolic syndrome. [PDF]
Qu Z, Guan X.
europepmc +1 more source
The predictive value of laboratory parameters for no-reflow phenomenon in patients with ST-elevation myocardial infarction following primary percutaneous coronary intervention: A meta-analysis. [PDF]
Wang L, Huang S, Zhou Q, Dou L, Lin D.
europepmc +1 more source
Electroacupuncture for slow flow/no-reflow phenomenon in patients with acute myocardial infarction undergoing percutaneous coronary intervention: protocol for a pilot randomized controlled trial. [PDF]
Peng Y +5 more
europepmc +1 more source

